《2018 ASA/AHA急性缺血性脑卒中患者早期管理指南》更新解读

被引:53
作者
吴川杰
宋海庆
机构
[1] 首都医科大学宣武医院神经内科
关键词
卒中; 二级预防; 治疗;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
2018年国际卒中大会上公布的《2018 ASA/AHA急性缺血性脑卒中患者早期管理指南》与前版指南相比有较大的变化,许多更新改变了目前的临床实践,其中最重要的几点包括早期血管再通治疗、院内急性期治疗和二级预防治疗。本文结合我国临床的实际情况对新版指南主要更新内容进行详细解读,以期为我国神经科临床实践提供参考。
引用
收藏
页码:1639 / 1644
页数:6
相关论文
共 12 条
[1]  
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial[J] . Nicola Logallo,Vojtech Novotny,J?rg Assmus,Christopher E Kvistad,Lars Alteheld,Ole Morten R?nning,Bente Thommessen,Karl-Friedrich Amthor,Hege Ihle-Hansen,Martin Kurz,H?kon Tobro,Kamaljit Kaur,Magdalena Stankiewicz,Maria Carlsson,?se,Morsund,Titto Idicula,Anne Hege Aamodt,Christian Lund,Halvor N?ss,Ulrike Waje-Andreassen,Lars Thomassen.The Lancet Neurol
[2]   Safety and Preliminary Efficacy of Early Tirofiban Treatment After Alteplase in Acute Ischemic Stroke Patients [J].
Li, Wei ;
Lin, Lu ;
Zhang, Meng ;
Wu, Ya ;
Liu, Chengchun ;
Li, Xiaoshu ;
Huang, Shuhan ;
Liang, Chunrong ;
Wang, Yanjiang ;
Chen, Jinhua ;
Feng, Wuwei .
STROKE, 2016, 47 (10) :2649-2651
[3]  
Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study[J] . Xuya Huang,Bharath Kumar Cheripelli,Suzanne M Lloyd,Dheeraj Kalladka,Fiona Catherine Moreton,Aslam Siddiqui,Ian Ford,Keith W Muir.The Lancet Neurology . 2015 (4)
[4]  
Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial[J] . Sanne M Zinkstok,Yvo B Roos.The Lancet . 2012 (9843)
[5]  
Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial[J] . Jeffrey L Saver,Reza Jahan,Elad I Levy,Tudor G Jovin,Blaise Baxter,Raul G Nogueira,Wayne Clark,Ronald Budzik,Osama O Zaidat.The Lancet . 2012 (9849)
[6]  
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial[J] . Raul G Nogueira,Helmi L Lutsep,Rishi Gupta,Tudor G Jovin,Gregory W Albers,Gary A Walker,David S Liebeskind,Wade S Smith.The Lancet . 2012 (9849)
[7]  
Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR[J] . Niaz Ahmed,Nils Wahlgren,Martin Grond,Michael Hennerici,Kennedy R Lees,Robert Mikulik,Mark Parsons,Risto O Roine,Danilo Toni,Peter Ringleb.Lancet Neurology . 2010 (9)
[8]  
Phase IIB/III Trial of Tenecteplase in Acute Ischemic Stroke: Results of a Prematurely Terminated Randomized Clinical Trial[J] . E. Clarke Haley,John L.P. Thompson,James C. Grotta,Patrick D. Lyden,Thomas G. Hemmen,Devin L. Brown,Christopher Fanale,Richard Libman,Thomas G. Kwiatkowski,Rafael H. Llinas,Steven R. Levine,Karen C. Johnston,Richard Buchsbaum,Gilberto Levy,Bruce Levin.Stroke . 2010 (4)
[9]  
Thrombolysis with Alteplase 3 to 4.5 Hours After Acute Ischemic Stroke[J] . W. Hacke,M. Kaste,E. Bluhmki.Journal of Vascular Surgery . 2008 (6)
[10]  
Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial[J] . Wade S. Smith,Gene Sung,Jeffrey Saver,Ronald Budzik,Gary Duckwiler,David S. Liebeskind,Helmi L. Lutsep,Marilyn M. Rymer,Randall T. Higashida,Sidney Starkman,Y Pierre Gobin.Stroke . 2008 (4)